Novo Nordisk to Acquire Obesity Drug Developer Inversago ...Middle East

Novo Nordisk has said it would acquire Canadian company Inversago Pharma in a $1.07 billion deal including the development of an appetite regulator. Reuters Health Information

Hence then, the article about novo nordisk to acquire obesity drug developer inversago was published today ( Friday 11/08/2023 - 04:40 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Nordisk to Acquire Obesity Drug Developer Inversago )

Also on site :

• 1985 Hit Novel, Written By a 21-Year-Old, Was Inspired By an Elvis Costello Song
• Beloved Romance Author Wants to Turn Jen Hamilton's Divorce Into Her Nex Best Seller — Under One Condition
• Netflix's 'The Idaho Murders: College Nightmare' Reveals These 10 Disturbing Details About the Bryan Kohberger Case